Impact of Comorbidities on Lung Cancer Screening Evaluation
CONCLUSION: Patient and procedure-level factors may alter the benefits of lung cancer screening. Data concerning individual risk factors and high-risk complications should therefore be incorporated into diagnostic algorithms to optimize clinical benefit and minimize harm. Further study and validation of the risk factors identified herein are warranted.PMID:35641376 | DOI:10.1016/j.cllc.2022.03.012
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Eric M Robinson Benjamin Y Liu Keith Sigel Chung Yin Juan Wisnivesky Minal S Kale Source Type: research
More News: Cancer | Cancer & Oncology | Chronic Obstructive Pulmonary | Colorectal Cancer | Diabetes | Diabetes Mellitus | Endocrinology | Kale | Lung Cancer | Ovarian Cancer | Ovaries | Prostate Cancer | Smokers | Stroke | Study